Cas:220554-75-6 2-[4,8-bis(2-amino-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetamide,hydroiodide manufacturer & supplier

We serve Chemical Name:2-[4,8-bis(2-amino-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetamide,hydroiodide CAS:220554-75-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-[4,8-bis(2-amino-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetamide,hydroiodide

Chemical Name:2-[4,8-bis(2-amino-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetamide,hydroiodide
CAS.NO:220554-75-6
Synonyms:1,4,8,11-Tetraazacyclotetradecane-1,4,8-triacetamide,monohydriodide (9CI);1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane monohydriodide;1,4,8,11-Tetraazacyclotetradecane-1,4,8-triacetamide,hydriodide (1:1);MFCD09265340;1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane hydriodide
Molecular Formula:C16H34IN7O3
Molecular Weight:499.39100
HS Code:2933990090

Physical and Chemical Properties:
Melting point:221-223ºC
Boiling point:691.3ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:151.02000
Exact Mass:499.17700
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,4,8,11-Tetraazacyclotetradecane-1,4,8-triacetamide,monohydriodide (9CI) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane hydriodide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD09265340 Use and application,1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane monohydriodide technical grade,usp/ep/jp grade.


Related News: In the Phase III VICTORIA study, Verquvo met the primary efficacy objective based on a time-to-event analysis. benzyl 4-(tert-butoxycarbonylamino) benzoate manufacturers Since it emerged as a shareholder of GSK in April, Elliott has reportedly been trying to gin up investor support to move Walmsley to the consumer health spinoff rather than to let her lead the new GSK after the separation. (3aS,6aS)-6a-Methyl-2-oxo-hexahydro-cyclopenta[b]furan-3-carboxylic acid suppliers The inhaled version was also found to trigger neutralising antibodies and T cell responses after one dose. 5-isobutyl-1,5-dimethyl-2-phenyl-1,5-dihydro-4H-imidazol-4-one vendor & factory.